U.S. Drug Delivery Devices Market to 2032

Overview

The U.S. Drug Delivery Devices Market is expected to reach a 1,222.33 USD Billion by 2032 and is projected to grow at a CAGR of 8.41% from 2025 to 2032.

Revenue, 2024 (USD Billion)
694.59
Forecast, 2032 (USD Billion)
1,222.33
CAGR, 2024 - 2032
8.41%
Report Coverage
U.S.

U.S. Drug Delivery Devices Market 2018-2032 USD Billion

U.S. Drug Delivery Devices Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 694.59 USD Billion
  • Projected Market Size (2032): 1,222.33 USD Billion
  • CAGR (2025-2032): 8.41%

Key Findings of U.S. Drug Delivery Devices Market

  • The U.S. Drug Delivery Devices Market was valued at 694.59 USD Billion in 2024.
  • The U.S. Drug Delivery Devices Market is likely to grow at a CAGR of 8.41% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Direct Tenders in Distribution Channel Segment accounted for the largest share of the market with a revenue of 449.71 USD Billion
  • The fastest growing segment Pharmacy Stores in Distribution Channel Segment grew Fastest with a CAGR of 10.34% during the forecast period from 2024 to 2032.

U.S. Drug Delivery Devices Market Scope

U.S. Drug Delivery Devices Market Segmentation & Scope
Distribution Channel
  • Online Pharmacy
  • Pharmacy Stores
  • Hospital Pharmacies
  • Direct Tenders
Product Type
  • Implantable Drug Delivery
  • Transmucosal Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Ophthalmic Drug Delivery
  • Topical Drug Delivery
  • Injectable Drug Delivery
  • Oral Drug Delivery
End User
  • Others
  • Community Healthcare
  • Clinics
  • Home Healthcare
  • Hospitals

U.S. Drug Delivery Devices Market Data Coverage Insights

Study Period 2024-2032
Base Year 2023
Unit Revenue in USD Billion
Market Value in 2024 694.59 USD Billion
Market Value in 2032 1,222.33 USD Billion
CAGR (2025-2032) 8.41%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,Product Type,End User

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 694.59 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 694,594.86 USD Million in 2024.

Segments and Scope

  • U.S. Drug Delivery Devices Market to 2032, By Distribution Channel
    • Direct Tenders is the largest segment in U.S. Drug Delivery Devices Market to 2032 with a revenue of 449.71 USD Billion in the year 2024.
    • Pharmacy Stores is the Fastest growing segment in U.S. Drug Delivery Devices Market to 2032 with a Growth rate of 8.33 % in forecast period 2025-2032.
  • U.S. Drug Delivery Devices Market to 2032, By Product Type
    • Oral Drug Delivery is the largest segment in U.S. Drug Delivery Devices Market to 2032 with a revenue of 268.08 USD Billion in the year 2024.
    • Injectable Drug Delivery is the Fastest growing segment in U.S. Drug Delivery Devices Market to 2032 with a Growth rate of 7.13 % in forecast period 2025-2032.
  • U.S. Drug Delivery Devices Market to 2032, By End User
    • Hospitals is the largest segment in U.S. Drug Delivery Devices Market to 2032 with a revenue of 258.28 USD Billion in the year 2024.
    • Home Healthcare is the Fastest growing segment in U.S. Drug Delivery Devices Market to 2032 with a Growth rate of 7.66 % in forecast period 2025-2032.

U.S. Drug Delivery Devices Market Company Share Analysis

 
Company Name Company Share Analysis
Novartis AG
Johnson & Johnson Services, Inc.
Pfizer Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
U.S. Drug Delivery Devices Market Company Share Analysis

U.S. Drug Delivery Devices Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Drug Delivery Devices Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Drug Delivery Devices Market Company Profiling

U.S. Drug Delivery Devices Market Company Profiling
Frequently Asked Questions
The U.S. Drug Delivery Devices Market is segmented based on Segmentation Distribution Channel,Product Type,End User.
U.S. Drug Delivery Devices Market was valued at USD 694.59(Revenue in USD Billion) in 2023.
U.S. Drug Delivery Devices Market is projected to grow at a CAGR of 8.41% during the forecast period of 2024 to 2032.
The Direct Tenders segment is expected to dominate the U.S. Drug Delivery Devices Market, holding a largest market share of 449.71 USD Billion in 2024

U.S. Drug Delivery Devices Market Scope

U.S. Drug Delivery Devices Market Segmentation & Scope
Distribution Channel
  • Online Pharmacy
  • Pharmacy Stores
  • Hospital Pharmacies
  • Direct Tenders
Product Type
  • Implantable Drug Delivery
  • Transmucosal Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Ophthalmic Drug Delivery
  • Topical Drug Delivery
  • Injectable Drug Delivery
  • Oral Drug Delivery
End User
  • Others
  • Community Healthcare
  • Clinics
  • Home Healthcare
  • Hospitals
Frequently Asked Questions
The U.S. Drug Delivery Devices Market is segmented based on Segmentation Distribution Channel,Product Type,End User.
U.S. Drug Delivery Devices Market was valued at USD 694.59(Revenue in USD Billion) in 2023.
U.S. Drug Delivery Devices Market is projected to grow at a CAGR of 8.41% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Drug Delivery Devices Market for final year is USD 1,222.33 (USD Billion).

U.S. Drug Delivery Devices Market Company Profiling

U.S. Drug Delivery Devices Market Company Profiling
Frequently Asked Questions
The U.S. Drug Delivery Devices Market is segmented based on Segmentation Distribution Channel,Product Type,End User.
U.S. Drug Delivery Devices Market was valued at USD 694.59(Revenue in USD Billion) in 2023.
U.S. Drug Delivery Devices Market is projected to grow at a CAGR of 8.41% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Drug Delivery Devices Market for final year is USD 1,222.33 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.